Hadassah

Hadassah Medical School Graduate Named Chief Executive Officer of Harvard’s Teaching Hospital--Beth Israel Deaconess Medical Center

Monday, Oct 24 2011

Dr. Kevin Tabb, a graduate of the Hadassah-Hebrew University School of Medicine, is the new President and CEO of Beth Israel Deaconess Medical Center, the teaching hospital of Harvard University.

Hadassah Medical School Graduate Named Chief Executive Officer of Harvard's Teaching Hospital--Beth Israel Deaconess Medical Center

Dr. Tabb was previously Chief Medical Officer at Stanford Hospital and Clinics (Stanford, CA). Raised in Berkeley, CA, Dr. Tabb emigrated to Israel at the age of 18. He also completed his residency in internal medicine at Hadassah. "We are thrilled to bring such a talented, thoughtful leader with a unique combination of skills to head our Medical Center," said Board Chair Stephen Kay. "As a physician with an extensive track record in hospital administration and business," he added, "Dr. Tabb has a deep understanding of integrated health care delivery that will keep BIDMC at the forefront of quality care."

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Thursday, Jan 11 2018

Hadassah’s Heart Institute: Innovation at the Forefront

Prof. Chaim Lotan, head of the Hadassah Medical Organization’s Heart Institute, has made it a personal objective to foster innovation in cardiovascular technology.

READ MORE ›
alt_text

Thursday, Jan 11 2018

Medical Clown Nehama’s Blog, Chapter Five: Out of Love

“I met Masha in the surgery waiting room at Hadassah Hospital Ein Kerem,” says Medical Clown Shira, as she proceeds to convey this story: Masha is a three-year-old girl who lives in Russia. Every three months, she comes to Hadassah for an oncological examination under full anesthesia.

READ MORE ›
alt_text

Wednesday, Jan 10 2018

Drug Company Collaborates with Hadassah Liver Specialist in Fighting Liver Disease

Dr. Rifaat Safadi, head of the Hadassah Medical Organization’s Liver Unit, in its Institute of Gastroenterology and Liver Diseases, is collaborating with Can-Fite BioPharma Ltd. to explore further the healing effects of a new drug that has proven in preclinical studies to mitigate inflammatory diseases of the liver, such as NASH (non-alcoholic steatohepatitis).

READ MORE ›
alt_text

Wednesday, Jan 10 2018

Bedridden Teen Walks Again, Thanks to First-in-Israel Complex Spinal Surgery at Hadassah

Yusef Rabaya, age 19, spent most of his life in bed at home in Jenin. Born with cerebral palsy (CP), he could sit only if he was propped up. Standing was excruciating and dangerous--and could cause permanent paralysis.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More